Private Wealth Asset Management’s AbbVie ABBV Stock Holding History

Private Wealth Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.09M	Sell	24,192 -641	-3%	-$138K	0.59%	35
2026 Q1	$5.4M	Buy	24,833 +1,028	+4%	+$228K	0.58%	36
2025 Q4	$5.44M	Buy	23,805 +600	+3%	+$137K	0.59%	39
2025 Q3	$5.37M	Buy	23,205 +3,607	+18%	+$735K	0.63%	35
2025 Q2	$3.64M	Buy	19,598 +264	+1%	+$49.1K	0.48%	41
2025 Q1	$4.05M	Buy	+19,334	New	+$3.76M	0.58%	35

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Private Wealth Asset Management's ABBV Position: Q2 2026 in Review

Private Wealth Asset Management reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $138K and leaving 24,192 shares worth $6.09M. The position accounts for 0.59% of the portfolio, ranked #35.

Private Wealth Asset Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Private Wealth Asset Management held 24,192 shares of AbbVie worth $6.09M as of Q2 2026.
Private Wealth Asset Management sold 641 AbbVie shares in Q2 2026, an estimated $138K.
AbbVie made up 0.59% of Private Wealth Asset Management's portfolio in Q2 2026, its #35 holding.
Private Wealth Asset Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.